In breast cancer cells, for example, nuclear import of p53 is inhibited by the expression of an importin α mutant with a truncation in the NLS-binding domain resulting in cytoplasmic retention of p53, inactivation of its tumor suppressor functions and tumorigenesis [13]. Here, TP53 is linked to breast cancer.